The importance of direct patient reporting of adverse drug reactions in the safety monitoring process
K Sienkiewicz, M Burzyńska… - International Journal of …, 2021 - mdpi.com
All medicinal products authorized in the European Union are subjects of constant drug-
safety monitoring processes. It is organized in a pharmacovigilance system that is designed …
safety monitoring processes. It is organized in a pharmacovigilance system that is designed …
[HTML][HTML] Patient and Family Engagement
V Dukhanin, SM Dy, R Sharma, M Vass… - … Healthcare Safer IV …, 2023 - ncbi.nlm.nih.gov
1. Background and Purpose The Agency for Healthcare Research and Quality (AHRQ)
Making Healthcare Safer (MHS) reports consolidate information for healthcare providers …
Making Healthcare Safer (MHS) reports consolidate information for healthcare providers …